These IBD 50 Stocks Are Stalled. That Could Be A Good Thing.
A few IBD 50 stocks are showing unusually narrow trading. Continue Reading
YENOM NOTICIAS
Qué está moviendo el mercado.
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
The 25-Year Stock Market Supercycle: Why The Biggest Acceleration Phase Is Still Ahead
Is a stock market supercycle underway? John Pocorobba breaks down how millennial demographics and AI could propel the market through 2035. Continue Reading
Exceptional Earnings and AI Immunity Fuel Hinge Health’s (HNGE) Performance
Osterweis Capital Management, an investment management firm, released its Q2 2026 investor update for its "Osterweis Opportunity Fund". You can download a copy of the letter here. The fund returned 35.34% in the quarter, significantly outp…
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
Hinge Health HNGE is well-positioned for sustained growth, driven by robust revenue growth, expanding opportunities in Migraine and gastrointestinal (GI) care and a scalable AI-powered MSK platform. The raised 2026 outlook, broader enterpr…
Is Hinge Health (HNGE) Still Undervalued As Its Digital Care Growth Draws Attention?
Jim Cramer put Hinge Health (HNGE) in the spotlight on a recent Mad Money lightning round, contrasting its rapid expansion with Aveanna Healthcare as investors reassess digital musculoskeletal care businesses. Hinge Health has been riding…
Jim Cramer Compares Aveanna Healthcare (AVAH) With Hinge Health (HNGE)
A caller asked for Jim Cramer's long-term thoughts on Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) during the lightning round of the September 14 episode of Mad Money. He replied: They have a good model. They remind me of Hinge, not exac…
Jim Cramer Believes Sphere Entertainment (SPHR) Is “Amazing”
Starting the lightning round of the September 11 episode, a caller asked if they should keep their "best winner" Sphere Entertainment Co. (NYSE:SPHR). Jim Cramer replied: Oh yeah, Sphere is really, I got to tell you, everyone at one point…
Jim Cramer Says He Thinks “You Hold on to Meta”
During the September 11 episode of Mad Money, a caller asked about Meta Platforms, Inc. (NASDAQ:META)'s recent AI launch and whether the company can successfully monetize its AI infrastructure for consumers over the next six to 12 months o…
Dow Jones Futures: S&P 500, Nasdaq Break Support; How Will Bonds React To Fed Rate Hike, Outlook?
The S&P 500 and Nasdaq undercut key support as oil prices and Treasury yields jumped. How will bonds react to the Federal Reserve decision. Continue Reading
IP Group H1 Earnings Call Highlights
Key Points Interested in IP Group Plc? Here are five stocks we like better. NAV per share rose 3.2% to 114p in the first half, exceeding £1 billion in total, and later reached approximately 117p, primarily due to a higher valuation for Oxf…
Apple, Taiwan Semi Lead Five Stocks Near Buy Points
Apple, which just unveiled its first foldable iPhone and two other new models that go on sale this week, and Taiwan Semiconductor Manufacturing, which makes the chips that power them, lead this weekend's watch list of five top stocks near…
Jim Cramer Explains Why He Added Hinge Health (HNGE) to His Fantasy Lineup
Expanding his fantasy stock lineup on Mad Money's episode aired on September 8, Jim Cramer turned his focus to digital healthcare provider Hinge Health, Inc. (NYSE:HNGE) to fill an important roster spot. He said: You need a tight end. This…
Match CEO: AI chatbot relationships could worsen the loneliness epidemic
Match Group (MTCH) CEO Spencer Rascoff is hoping a product revamp at Tinder could do its part in addressing the loneliness epidemic — which may only get worse because of AI companions. "There is a loneliness epidemic. It is existential for…
Hinge Health Director Kristina Leslie Sells 1,200 Shares for $105,876
Kristina M. Leslie, a Director at Hinge Health (NYSE:HNGE), disposed of 1,200 shares of Class A common stock on Aug. 20, 2026, according to a recent SEC Form 4 filing. Transaction summary Metric Value Shares sold (directly held) 1,200 Tran…
Hinge Health Inc. (HNGE) Up 13.7% Since Last Earnings Report: Can It Continue?
A month has gone by since the last earnings report for Hinge Health Inc. (HNGE). Shares have added about 13.7% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the recent positive trend continue leadi…
Judi Health™ Adds Color Health, WellTheory, and Cylinder to Its Expanding Clinical Partner Ecosystem
A growing roster of high-touch clinical programs now includes best-in-class solutions across cancer care, autoimmune and inflammatory conditions, gastrointestinal health, musculoskeletal care, and family building – all available through an…
Could Hinge Health (HNGE) Stock Win as Digital Healthcare Expands Beyond MSK Care?
Hinge Health, Inc. (NYSE:HNGE) raised its full-year 2026 revenue guidance to between $856 million and $860 million, well above consensus estimates of $822.16 million. The upbeat outlook follows a standout Q2 2026 performance where revenue…
Can Atrium Therapeutics (RNA)’s $15 Million Milestone From Bristol-Myers Squibb (BMY) Validate its RNA Platform?
On August 13, two pharmaceutical companies tied to the same cardiovascular research deal delivered major updates. Atrium Therapeutics, Inc. (NASDAQ:RNA) earned a $15 million milestone payment from Bristol-Myers Squibb Company (NYSE:BMY) af…
Hinge Health Catapults 95%; Expands Footprint In AI Pain Management
Hinge Health offers an app-based artificial intelligence-enabled program for managing pain and has been growing its client base as demand surges for its products and services. It staged its initial public offering on May 22, 2025, at an IP…
HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue?
Hinge Health HNGE stock has surged nearly 90% year to date, significantly outperforming the industry's 1.7% gain and the S&P 500's 12.6% rise. The sharp rally reflects growing investor confidence in the company's strong growth trajectory,…
Reasons to Hold Hinge Health Stock in Your Portfolio for Now
Hinge Health HNGE is well-positioned for sustained growth, driven by robust revenue growth, expanding opportunities in Migraine and gastrointestinal (GI) care and a scalable AI-powered MSK platform. The raised 2026 outlook, broader enterpr…
Jim Cramer says one stock hitting new highs is still a screaming buy
Jim Cramer fired a triple buy call Aug. 11 on the "Mad Money" Lightning Round. It came for a stock most people still have not heard of. He backed it up with four words that tell you exactly why. Let's see where he finds that conviction cal…
Hinge Health (HNGE) Just Bought Its Way Into A New Market, So Now What?
On August 4, Hinge Health (NASDAQ:HNGE) delivered a quarter that beat its own guidance on nearly every line, then turned around and used the extra cash to buy its way into a brand new category. Revenue grew 53% year-over-year, margins expa…
Boost Your Portfolio Returns With These 4 Top-Ranked Liquid Stocks
Investors looking for solid gains should benefit from adding stocks with sound liquidity, which encourages business growth. Liquidity measures a company's capability to meet short-term debt obligations. Stocks with high liquidity levels ha…
Can Weight-Loss Momentum Lift Hims & Hers Stock Before Q2 Earnings?
Hims & Hers Health, Inc. HIMS is scheduled to report second-quarter 2026 results on Aug. 10, after the closing bell. In the last reported quarter, the company's loss per share of 18 cents lagged the Zacks Consensus Estimate of earnings per…
Hinge Health expands into gastrointestinal care with $105M acquisition
This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Dive Brief: Hinge Health is expanding into gastrointestinal care through the acquisition of…
HNGE Q2 Earnings Meet Estimates, Sales Top, '26 View Raised, Stock Up
Hinge Health, Inc. HNGE reported second-quarter 2026 adjusted earnings per share (EPS) of 59 cents, in line with the Zacks Consensus Estimate. The bottom line increased 96.7% year over year. GAAP EPS for the quarter was 52 cents compared t…
Hinge Health, Inc. Q2 2026 Earnings Call Summary
Hinge Health, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Performance and Platform Expansion Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 p…
Hinge Health forecasts $856M-$860M 2026 revenue as it plans broader GI rollout in 2027
Earnings Call Insights: Hinge Health (HNGE) Q2 2026 MANAGEMENT VIEW * "Q2 was an outstanding quarter across the board" (CEO Daniel Perez) as the company highlighted product expansion beyond MSK, saying it is "moving from being a clear lead…
Hinge Health Inc. (HNGE) Q2 Earnings Meet Estimates
Hinge Health Inc. (HNGE) came out with quarterly earnings of $0.59 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.67 per share a year ago. These figures are adjusted for non-recurring items. A quarte…
Read Between These Lines As Eli Lilly, Hot IPO And More Face Key Test
As stocks like Eli Lilly, Twilio, Hinge Health and more move ahead of earnings report, pay attention to these chart lines. Continue Reading
AMD Stock Rebounds With Chips Ahead Of Q2 Report; SpaceX Earnings, Lockup Expiration Loom Large
AMD stock keeps its latest pullback contained compared with many other chip stocks as its second-quarter earnings report looms large. Continue Reading
Resmed's Q4 Earnings on Deck: What's in Store for the Stock?
Resmed RMD is set to release fourth-quarter fiscal 2026 results on Aug. 6, after the closing bell. The renowned sleep health device maker posted adjusted earnings per share (EPS) of $2.86 in the last reported quarter, surpassing the Zacks…
Hinge Health (HNGE) Rose with Expanding Client Base
Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for "Meridian Small Cap Growth Fund". A copy of the letter can be downloaded here. The U.S. market saw a strong rally in the second quarter, fu…
Bio-Techne's Q4 Earnings on Deck: What's in Store for the Stock?
Bio-Techne Corporation TECH is expected to release fourth-quarter fiscal 2026 results on Aug. 5. The life science and diagnostic product maker posted adjusted earnings per share (EPS) of 53 cents in the last reported quarter, missing the Z…
STERIS' Q1 Earnings on Deck: What's in Store for the Stock?
STERIS plc STE is scheduled to release first-quarter fiscal 2027 results on Aug. 6, after market close. In the last reported quarter, the company posted adjusted earnings per share (EPS) of $2.83, which missed the Zacks Consensus Estimate…